First German EVBA Procedure is Performed with New Heart Failure Therapy Approach streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
IRVINE, Calif. (BUSINESS WIRE) Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, has announced the closing of its $20 million financing round led by an investment partner of VDI s.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Positive Preliminary Clinical Trial Results Reported for Vascular Dynamics’ Novel Heart Failure Treatment Technology
February 9, 2021 GMT
IRVINE, Calif. (BUSINESS WIRE) Feb 9, 2021
Vascular Dynamics, Inc., a privately held medical device company focused on innovative, endovascular device-based solutions for cardiovascular conditions, has announced positive preliminary results from its clinical trial, “A Feasibility Study Exploring the Effect of the MobiusHD ® Device in Patients with Heart Failure.”
ADVERTISEMENT
Horst Sievert, MD, Director of the CardioVascular Center in Frankfurt, Germany, and Tamaz Shaburishvili, MD, Head of the Cardiovascular Clinic at Tbilisi Heart and Vascular Clinic in Tbilisi, Georgia, shared preliminary results of the clinical trial as part of a CSI Focus D-HF webinar presented last week.